Cargando…
Is immunization with palivizumab really effective in high-risk children?
The aim of this research is to determine the specific characteristics of the immunized children during a 15-year period and the readmissions to hospital due to potential infections of the respiratory tract. MATERIAL AND METHODS: This retrospective cohort study was conducted in the period from Octobe...
Autores principales: | Raguž, Marjana Jerković, Božić, Tomica, Nikše, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032334/ https://www.ncbi.nlm.nih.gov/pubmed/36811495 http://dx.doi.org/10.34763/jmotherandchild.20222601.d-22-00049 |
Ejemplares similares
-
Does Body Mass Index in Pregnant Women Affect Laboratory Parameters in the Newborn?
por: Raguž, Marjana Jerković, et al.
Publicado: (2016) -
Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021) -
Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis
por: Anderson, Evan J., et al.
Publicado: (2017) -
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
por: Homaira, Nusrat, et al.
Publicado: (2014) -
The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)